International Biotechnology Trust (LSE:IBT) PEG Ratio: N/A (As of Jul. 26, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LSE:IBT International Biotechnology Trust PLC LSE:IBT
36 GF Score
Price £10.85
! 4 Warning Signs
View Full Analysis

What is International Biotechnology Trust PEG Ratio?

PE Ratio without NRI / 5-Year Book Value Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use for banks is the 5-Year Book Value growth rate. As of today, International Biotechnology Trust's PE Ratio without NRI is 4.52. International Biotechnology Trust's 5-Year Book Value growth rate is -0.20%. Therefore, International Biotechnology Trust's PEG Ratio for today is N/A.

* The 5-Year Book Value Growth Rate is the 5-year average Book Value per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for International Biotechnology Trust's PEG Ratio or its related term are showing as below:


During the past 13 years, International Biotechnology Trust's highest PEG Ratio was 47.89. The lowest was 0.09. And the median was 1.43.


LSE:IBT's PEG Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 1.895
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


International Biotechnology Trust  (LSE:IBT) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


International Biotechnology Trust PEG Ratio Related Terms


International Biotechnology Trust PEG Ratio Historical Data

* Premium members only.

The historical data trend for International Biotechnology Trust's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

International Biotechnology Trust PEG Ratio Chart

International Biotechnology Trust Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24 Aug25
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.12 0.00 43.56 3.32 0.00

International Biotechnology Trust Semi-Annual Data
Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24 Aug24 Feb25 Aug25 Feb26
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 3.32 0.00 0.00 0.00

LSE:IBT vs VRTX, REGN, RVMD: PEG Ratio Comparison

For the Biotechnology subindustry, International Biotechnology Trust's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


International Biotechnology Trust PEG Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, International Biotechnology Trust's PEG Ratio distribution charts can be found below:

* The bar in red indicates where International Biotechnology Trust's PEG Ratio falls into.


LSE:IBT
36GF Score
International Biotechnology Trust PLC LSE:IBT
PEG Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

International Biotechnology Trust PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year Book Value growth rate.

International Biotechnology Trust's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year Book Value Growth Rate*
=4.5189504373178/-0.20
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year Book Value Growth Rate is the 5-year average Book Value per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


International Biotechnology Trust Business Description

Address 1 London Wall Place, London, GBR, EC2Y 5AU
International Biotechnology Trust PLC is an investment trust company. It aims at achieving long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which has good growth prospects. It focuses on investments in biotechnology companies which are engaged in on drug discovery and development, medical devices companies and healthcare services provider. The invests in various financial instruments such as equities, index-linked securities, debt securities, cash deposits, money market instruments ,and foreign currency exchange transactions. Its revenue comprises of dividend, interest and other income from investment made.
36GF Score

Get the complete analysis for LSE:IBT

PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£10.85
Price